Accessibility and reading comfort

Text size

Light/Dark mode

Lines vertical spacing

Trouble using our website?
Contact us

REC 0/​0559 Eye Drops for Treatment of Moderate and Severe Neurotrophic Keratitis in Adult Patients

In this page

Clinical Trial

NCT04276558 Recruiting, Active
REC 0/​0559 Eye Drops for Treatment of Moderate and Severe Neurotrophic Keratitis in Adult Patients

Efficacy, Safety and Pharmacokinetics of 3 Doses of REC 0/0559 Eye Drops for the Treatment of Stage 2 (Moderate) and 3 (Severe) Neurotrophic Keratitis in Adult Patients

Phase 2
Interventional

Disease

Disease type

Other

Patient type

Adult

Children

Inclusion / Exclusion

Opening date

13/10/2020

Closing date

30/04/2024

Inclusion criteria :

More

Exclusion criteria :

More

Funding

private

Members involved

Others investigators

Dr Claudia Priglinger

Representative

Germany

See more

Dr Yannick Lemer

Representative

France

See more

Pr Dominique BREMOND-GIGNAC

Representative

France

Anterior Segment Rare Eye Diseases (WG4), CPMS & Digital Medecine (TWG10), Genetic Diagnostics (TWG6), Low Vision Daily Life and Patients Groups (TWG5), National Integration (TWG9), Neuro-Ophthalmology Rare Diseases (WG2), Pediatric Ophthalmology Rare Diseases (WG3), Registries & Epidemiology (TWG7), Research (TWG8), Retinal Rare Eye Diseases (WG1)
Working Group Leader
See more

Pr Philipp Albrecht

Representative

Germany

See more

Dr Giacomo Maria Bacci

Substitute

Italy

Anterior Segment Rare Eye Diseases (WG4), Genetic Diagnostics (TWG6), Low Vision Daily Life and Patients Groups (TWG5), Pediatric Ophthalmology Rare Diseases (WG3), Retinal Rare Eye Diseases (WG1)
See more

Dr JAIME ETXEBARRIA

Representative

Spain

Anterior Segment Rare Eye Diseases (WG4)
See more

Pr Julian Garcia Feijoo

Representative

Spain

CPMS & Digital Medecine (TWG10), Genetic Diagnostics (TWG6), Low Vision Daily Life and Patients Groups (TWG5), National Integration (TWG9), Pediatric Ophthalmology Rare Diseases (WG3), Research (TWG8)
See more

ERN EYE member investigating site

HCP : Principal investigators

OPHTARA – AP-HP, Hôpital Necker-Enfants Malades, Paris, France

Adress

Service d'ophtalmologieBât. Lecourbe - RC149 rue de Sèvres

75 015 Paris

France